Abstract
Isavuconazole is an extended-spectrum triazole with in vitro activity against a wide variety of fungal pathogens. Clinical isolates of molds Aspergillus lentulus and Neosartorya udagawae and yeast Cryptococcus gattii VGII (implicated in the outbreak in the Pacific Northwest, North America) exhibit reduced susceptibilities to several azoles but higher susceptibilities to isavuconazole.
Original language | English (US) |
---|---|
Pages (from-to) | 3090-3093 |
Number of pages | 4 |
Journal | Journal of clinical microbiology |
Volume | 51 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2013 |
ASJC Scopus subject areas
- Microbiology (medical)